257 related articles for article (PubMed ID: 19910613)
21. [Combination treatment with inhaled corticosteroid/long-acting beta 2-adrenergic bronchodilator in the treatment of asthma].
Kimura T; Adachi M
Nihon Rinsho; 2001 Oct; 59(10):1992-9. PubMed ID: 11676144
[TBL] [Abstract][Full Text] [Related]
22. Predictors of a more favourable response to combined therapy with salmeterol and fluticasone as initial maintenance therapy in asthma.
Ernst P; Franssen E; Chan CK; Okell M; O'Byrne P; Bai T
Respir Med; 2008 Jan; 102(1):77-81. PubMed ID: 17904834
[TBL] [Abstract][Full Text] [Related]
23. Impact of the Arg 16 allele of the B2AR gene on the effect of withdrawal of LABA in patients with moderate to severe asthma.
Slankard M; Michelis MA; Mansukhani M; McGoey B; Paige A; Andrews H; Lederer D; Canfield S; DiMango E
J Asthma; 2016 Oct; 53(8):783-9. PubMed ID: 27050801
[TBL] [Abstract][Full Text] [Related]
24. Influence of β(2)-adrenergic receptor polymorphisms on asthma exacerbation in children with severe asthma regularly receiving salmeterol.
Giubergia V; Gravina L; Castaños C; Chertkoff L
Ann Allergy Asthma Immunol; 2013 Mar; 110(3):156-60. PubMed ID: 23548523
[TBL] [Abstract][Full Text] [Related]
25. beta-Adrenergic receptor polymorphisms and response to salmeterol.
Wechsler ME; Lehman E; Lazarus SC; Lemanske RF; Boushey HA; Deykin A; Fahy JV; Sorkness CA; Chinchilli VM; Craig TJ; DiMango E; Kraft M; Leone F; Martin RJ; Peters SP; Szefler SJ; Liu W; Israel E;
Am J Respir Crit Care Med; 2006 Mar; 173(5):519-26. PubMed ID: 16322642
[TBL] [Abstract][Full Text] [Related]
26. [A fixed combination of fluticasone and salmeterol permits better control of asthma than a beclomethasone dipropionate and montelukast combination].
Grosclaude M; Cerruti JL; Delannay B; Hérent M; Spilthooren F; Desfougères JL
Eur Ann Allergy Clin Immunol; 2003 Nov; 35(9):356-62. PubMed ID: 14716965
[TBL] [Abstract][Full Text] [Related]
27. The effect of polymorphisms of the beta(2)-adrenergic receptor on the response to regular use of albuterol in asthma.
Israel E; Drazen JM; Liggett SB; Boushey HA; Cherniack RM; Chinchilli VM; Cooper DM; Fahy JV; Fish JE; Ford JG; Kraft M; Kunselman S; Lazarus SC; Lemanske RF; Martin RJ; McLean DE; Peters SP; Silverman EK; Sorkness CA; Szefler SJ; Weiss ST; Yandava CN
Am J Respir Crit Care Med; 2000 Jul; 162(1):75-80. PubMed ID: 10903223
[TBL] [Abstract][Full Text] [Related]
28. Cross tolerance to salbutamol occurs independently of beta2 adrenoceptor genotype-16 in asthmatic patients receiving regular formoterol or salmeterol.
Lee DK; Jackson CM; Bates CE; Lipworth BJ
Thorax; 2004 Aug; 59(8):662-7. PubMed ID: 15282385
[TBL] [Abstract][Full Text] [Related]
29. Initiation of maintenance treatment with salmeterol/fluticasone propionate 50/100 microg bd versus fluticasone propionate 100 microg bd alone in patients with persistent asthma: integrated analysis of four randomised trials.
Barnes NC; Jacques L; Goldfrad C; Bateman ED
Respir Med; 2007 Nov; 101(11):2358-65. PubMed ID: 17689947
[TBL] [Abstract][Full Text] [Related]
30. Lung function response to 12-week treatment with combined inhalation of long-acting beta2 agonist and glucocorticoid according to ADRB2 polymorphism in patients with chronic obstructive pulmonary disease.
Kim WJ; Oh YM; Sung J; Kim TH; Huh JW; Jung H; Lee JH; Kim EK; Lee JH; Lee SM; Lee S; Lim SY; Shin TR; Yoon HI; Kwon SY; Lee SD
Lung; 2008; 186(6):381-6. PubMed ID: 18758858
[TBL] [Abstract][Full Text] [Related]
31. Adrenergic beta(2)-receptor genotype predisposes to exacerbations in steroid-treated asthmatic patients taking frequent albuterol or salmeterol.
Basu K; Palmer CN; Tavendale R; Lipworth BJ; Mukhopadhyay S
J Allergy Clin Immunol; 2009 Dec; 124(6):1188-94.e3. PubMed ID: 19800676
[TBL] [Abstract][Full Text] [Related]
32. Functional antagonism with formoterol and salmeterol in asthmatic patients expressing the homozygous glycine-16 beta(2)-adrenoceptor polymorphism.
Lipworth BJ; Dempsey OJ; Aziz I
Chest; 2000 Aug; 118(2):321-8. PubMed ID: 10936119
[TBL] [Abstract][Full Text] [Related]
33. Association between beta 2-adrenoceptor polymorphism and susceptibility to bronchodilator desensitisation in moderately severe stable asthmatics.
Tan S; Hall IP; Dewar J; Dow E; Lipworth B
Lancet; 1997 Oct; 350(9083):995-9. PubMed ID: 9329515
[TBL] [Abstract][Full Text] [Related]
34. Adverse effects of salmeterol in asthma: a neuronal perspective.
Lommatzsch M; Lindner Y; Edner A; Bratke K; Kuepper M; Virchow JC
Thorax; 2009 Sep; 64(9):763-9. PubMed ID: 19237390
[TBL] [Abstract][Full Text] [Related]
35. Beta2-adrenergic receptor polymorphisms affect response to treatment in children with severe asthma exacerbations.
Carroll CL; Stoltz P; Schramm CM; Zucker AR
Chest; 2009 May; 135(5):1186-1192. PubMed ID: 19029431
[TBL] [Abstract][Full Text] [Related]
36. Arginine-16 beta2 adrenoceptor genotype predisposes to exacerbations in young asthmatics taking regular salmeterol.
Palmer CN; Lipworth BJ; Lee S; Ismail T; Macgregor DF; Mukhopadhyay S
Thorax; 2006 Nov; 61(11):940-4. PubMed ID: 16772309
[TBL] [Abstract][Full Text] [Related]
37. Asthma exacerbations during long term beta agonist use: influence of beta(2) adrenoceptor polymorphism.
Taylor DR; Drazen JM; Herbison GP; Yandava CN; Hancox RJ; Town GI
Thorax; 2000 Sep; 55(9):762-7. PubMed ID: 10950895
[TBL] [Abstract][Full Text] [Related]
38. Meta-analysis of the risk of mortality with salmeterol and the effect of concomitant inhaled corticosteroid therapy.
Weatherall M; Wijesinghe M; Perrin K; Harwood M; Beasley R
Thorax; 2010 Jan; 65(1):39-43. PubMed ID: 20029037
[TBL] [Abstract][Full Text] [Related]
39. Effect of interleukin 13 on bronchial hyperresponsiveness and the bronchoprotective effect of beta-adrenergic bronchodilators and corticosteroids.
Townley RG; Gendapodi PR; Qutna N; Evans J; Romero FA; Abel P
Ann Allergy Asthma Immunol; 2009 Mar; 102(3):190-7. PubMed ID: 19354064
[TBL] [Abstract][Full Text] [Related]
40. Tailored second-line therapy in asthmatic children with the Arg(16) genotype.
Lipworth BJ; Basu K; Donald HP; Tavendale R; Macgregor DF; Ogston SA; Palmer CN; Mukhopadhyay S
Clin Sci (Lond); 2013 Apr; 124(8):521-8. PubMed ID: 23126384
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
